Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene (ExCentric)
This study is currently recruiting participants.
Verified July 2011 by Northern Sydney and Central Coast Area Health Service
Sponsor:
Northern Sydney and Central Coast Area Health Service
Collaborator:
Merck KGaA
Information provided by:
Northern Sydney and Central Coast Area Health Service
ClinicalTrials.gov Identifier:
NCT01124240
First received: May 13, 2010
Last updated: July 25, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |